Malignant phyllodes tumors of the breast: the malignancy grading and associations with prognosis
- PMID: 37071267
- DOI: 10.1007/s10549-023-06933-z
Malignant phyllodes tumors of the breast: the malignancy grading and associations with prognosis
Abstract
Purpose: This study aimed to correlate clinicopathological parameters with survival outcomes in a cohort of patients diagnosed with malignant phyllodes tumors (MPTs). We also analyzed the malignancy grade of MPTs and investigated the prognostic significance of the malignancy grading system.
Methods: Clinicopathological parameters, malignancy grades, and clinical follow-up data of 188 women diagnosed with MPTs in a single-institution were analyzed. MPTs of the breast were grouped according to stromal atypia, stromal overgrowth, mitotic count, tumor differentiation, and necrosis. A Fleiss' kappa statistic was calculated to test the agreement between the pathologists for the grading of MPTs. Disease-free survival (DFS), distant metastasis-free survival (DMFS) and overall survival (OS) were estimated using the Kaplan-Meier method and compared between groups using the log-rank test. Cox regression was carried out to identify factors predictive of locoregional recurrence (LRR), distant metastasis (DM) and death.
Results: A total of 188 MPTs were classified according to the malignancy grading system: 88 (46.8%) as low grade, 77 (41%) as an intermediate grade, and 23 (12.2%) as high grade. Excellent agreement between pathologists for the grading of MPTs (Fleiss' kappa 0.807). In our study population, the occurrence of DM and death were associated with the malignancy grade of MPTs (P < 0.001). Based on the DFS curves, the presence of heterologous elements (P = 0.025) and younger age (P = 0.014) were independent prognostic indicators. Additionally, the malignancy grade retained independent prognostic significance for predicting DMFS and OS (P < 0.001 and P = 0.009).
Conclusions: Higher malignancy grade, presence of heterologous elements, younger age, larger tumor size, and recent rapid tumor growth are poor prognostic factors for MPTs of the breast. The malignancy grading system may be generalized in the future.
Keywords: Heterologous elements; Malignancy grade; Malignant phyllodes tumors; Prognosis.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Validation Study of the Newly Proposed Refined Diagnostic Criteria for Malignant Phyllodes Tumor With 136 Borderline and Malignant Phyllodes Tumor Cases.Am J Surg Pathol. 2024 Sep 1;48(9):1146-1153. doi: 10.1097/PAS.0000000000002264. Epub 2024 Jun 27. Am J Surg Pathol. 2024. PMID: 38934254
-
Retrospective study of malignant phyllodes tumors of the breast: Younger age, prior fibroadenoma surgery, malignant heterologous elements and surgical margins may predict recurrence.Breast. 2021 Jun;57:62-70. doi: 10.1016/j.breast.2021.03.001. Epub 2021 Mar 17. Breast. 2021. PMID: 33774460 Free PMC article.
-
Predictive factors for the local recurrence and distant metastasis of phyllodes tumors of the breast: a retrospective analysis of 192 cases at a single center.Chin J Cancer. 2014 Oct;33(10):492-500. doi: 10.5732/cjc.014.10048. Epub 2014 Aug 8. Chin J Cancer. 2014. PMID: 25104281 Free PMC article.
-
Prognostic factors of breast phyllodes tumors.Histol Histopathol. 2023 Aug;38(8):865-878. doi: 10.14670/HH-18-600. Epub 2023 Feb 27. Histol Histopathol. 2023. PMID: 36866915 Review.
-
A retrospective review of phyllodes tumors of the breast from a single institution.Breast Dis. 2021;40(S1):S63-S70. doi: 10.3233/BD-219009. Breast Dis. 2021. PMID: 34092583 Review.
Cited by
-
Malignant phyllodes tumours of the breast: the case for revising WHO's 'full house' diagnostic criteria.Histopathology. 2025 Aug;87(2):169-182. doi: 10.1111/his.15455. Epub 2025 Apr 13. Histopathology. 2025. PMID: 40223225 Free PMC article. Review.
-
NKILA is a novel suppressor of local recurrence in women breast malignant phyllodes tumor patients via inhibition of the NF-κB pathway.Heliyon. 2024 Jun 20;10(13):e33259. doi: 10.1016/j.heliyon.2024.e33259. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39027510 Free PMC article.
-
Malignant phyllodes tumor of the breast with predominant osteosarcoma and chondrosarcomatous differentiation: a rare case report and review of literature.Front Oncol. 2024 Apr 19;14:1372710. doi: 10.3389/fonc.2024.1372710. eCollection 2024. Front Oncol. 2024. PMID: 38706594 Free PMC article.
-
Clinicopathological features and risk factors for local recurrence of breast phyllodes tumors: a dual-center, 12-year, retrospective study.Front Oncol. 2025 May 26;15:1538523. doi: 10.3389/fonc.2025.1538523. eCollection 2025. Front Oncol. 2025. PMID: 40492129 Free PMC article.
References
-
- Alloson Kimberly H, Brogi Edi, Ellis Ian O et al (2019) WHO classification of tumours editorial board. Breast tumours. WHO, Lyon
-
- Vorherr H, Vorherr UF, Kutvirt DM et al (1985) Cystosarcoma phyllodes: epidemiology, pathohistology, pathobiology, diagnosis, therapy, and survival. Arch Gynecol 36:173–181 - DOI
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical